Northern Trust
ZBIO

Northern Trust’s Zenas BioPharma ZBIO Stock Holding History

Northern Trust’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.81M Buy
194,640
+39,274
+25% +$882K ﹤0.01% 2614
2025
Q4 		$5.64M Buy
155,366
+22,088
+17% +$726K ﹤0.01% 2404
2025
Q3 		$2.96M Buy
133,278
+13,763
+12% +$224K ﹤0.01% 2816
2025
Q2 		$1.16M Sell
119,515
-723
-0.6% -$7.04K ﹤0.01% 3303
2025
Q1 		$950K Sell
120,238
-4,008
-3% -$31.4K ﹤0.01% 3307
2024
Q4 		$1.02M Buy
+124,246
New +$1.94M ﹤0.01% 3384

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Northern Trust's ZBIO Position: Q1 2026 in Review

Northern Trust increased its Zenas BioPharma (ZBIO) stake by 25% in Q1 2026, buying an estimated $882K and bringing the position to 194,640 shares worth $3.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2614.

Northern Trust first reported a position in ZBIO in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.64M in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • Northern Trust held 194,640 shares of Zenas BioPharma worth $3.81M as of Q1 2026.
  • Northern Trust bought 39,274 Zenas BioPharma shares in Q1 2026, an estimated $882K.
  • Zenas BioPharma made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2614 holding.
  • Northern Trust first reported a position in Zenas BioPharma in Q4 2024 and has held it in 6 quarters since.
  • Northern Trust's Zenas BioPharma position peaked at $5.64M in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.